# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001564590-19-041036
Filing Date
2019-11-06
Accepted
2019-11-06 16:15:53
Documents
43
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | abio-8k_20191106.htm | 8-K | 37629
2 | EX-99.1 | abio-ex991_6.htm | EX-99.1 | 175522
3 | EX-99.2 | abio-ex992_113.htm | EX-99.2 | 45312
4 | GRAPHIC | gd2uz1ymw5ks000009.jpg | GRAPHIC | 251736
5 | GRAPHIC | gd2uz1ymw5ks000002.jpg | GRAPHIC | 517883
6 | GRAPHIC | gd2uz1ymw5ks000033.jpg | GRAPHIC | 410870
7 | GRAPHIC | g0xeaxezps3s000001.jpg | GRAPHIC | 20861
8 | GRAPHIC | gd2uz1ymw5ks000023.jpg | GRAPHIC | 309968
9 | GRAPHIC | gd2uz1ymw5ks000036.jpg | GRAPHIC | 329801
10 | GRAPHIC | gd2uz1ymw5ks000027.jpg | GRAPHIC | 320962
11 | GRAPHIC | gd2uz1ymw5ks000013.jpg | GRAPHIC | 351558
12 | GRAPHIC | gd2uz1ymw5ks000030.jpg | GRAPHIC | 382032
13 | GRAPHIC | gd2uz1ymw5ks000011.jpg | GRAPHIC | 357066
14 | GRAPHIC | gd2uz1ymw5ks000010.jpg | GRAPHIC | 278741
15 | GRAPHIC | gd2uz1ymw5ks000037.jpg | GRAPHIC | 211896
16 | GRAPHIC | gd2uz1ymw5ks000003.jpg | GRAPHIC | 333522
17 | GRAPHIC | gd2uz1ymw5ks000012.jpg | GRAPHIC | 464348
18 | GRAPHIC | gd2uz1ymw5ks000007.jpg | GRAPHIC | 315983
19 | GRAPHIC | gd2uz1ymw5ks000029.jpg | GRAPHIC | 238363
20 | GRAPHIC | gd2uz1ymw5ks000032.jpg | GRAPHIC | 396810
21 | GRAPHIC | gd2uz1ymw5ks000004.jpg | GRAPHIC | 311516
22 | GRAPHIC | gd2uz1ymw5ks000025.jpg | GRAPHIC | 372119
23 | GRAPHIC | gd2uz1ymw5ks000008.jpg | GRAPHIC | 244056
24 | GRAPHIC | gd2uz1ymw5ks000014.jpg | GRAPHIC | 355336
25 | GRAPHIC | gd2uz1ymw5ks000034.jpg | GRAPHIC | 269430
26 | GRAPHIC | gd2uz1ymw5ks000015.jpg | GRAPHIC | 325807
27 | GRAPHIC | gd2uz1ymw5ks000024.jpg | GRAPHIC | 322117
28 | GRAPHIC | gd2uz1ymw5ks000001.jpg | GRAPHIC | 477057
29 | GRAPHIC | gd2uz1ymw5ks000026.jpg | GRAPHIC | 305812
30 | GRAPHIC | gd2uz1ymw5ks000039.jpg | GRAPHIC | 466711
31 | GRAPHIC | gd2uz1ymw5ks000028.jpg | GRAPHIC | 283223
32 | GRAPHIC | gd2uz1ymw5ks000006.jpg | GRAPHIC | 365378
33 | GRAPHIC | gd2uz1ymw5ks000038.jpg | GRAPHIC | 148574
34 | GRAPHIC | gd2uz1ymw5ks000005.jpg | GRAPHIC | 248476
35 | GRAPHIC | gd2uz1ymw5ks000035.jpg | GRAPHIC | 238907
36 | GRAPHIC | gd2uz1ymw5ks000016.jpg | GRAPHIC | 274263
37 | GRAPHIC | gd2uz1ymw5ks000020.jpg | GRAPHIC | 321278
38 | GRAPHIC | gd2uz1ymw5ks000017.jpg | GRAPHIC | 458140
39 | GRAPHIC | gd2uz1ymw5ks000031.jpg | GRAPHIC | 318518
40 | GRAPHIC | gd2uz1ymw5ks000021.jpg | GRAPHIC | 300555
41 | GRAPHIC | gd2uz1ymw5ks000019.jpg | GRAPHIC | 460991
42 | GRAPHIC | gd2uz1ymw5ks000022.jpg | GRAPHIC | 376581
43 | GRAPHIC | gd2uz1ymw5ks000018.jpg | GRAPHIC | 269138
| Complete submission text file | 0001564590-19-041036.txt |  | 18176144

Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 191196484
SIC: 2835 In Vitro & In Vivo Diagnostic Substances